Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ICU
ICU logo

ICU

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ICU News

SeaStar Medical Reports Improved Q4 Results with Revenue Growth

4d agoNASDAQ.COM

SeaStar Medical Reports Key 2025 Financial Highlights

5d agoYahoo Finance

SeaStar Medical Q4 Earnings Beat Expectations

5d agoseekingalpha

SEASTAR MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS ALONG WITH BUSINESS UPDATES

5d agomoomoo

Life Sciences Virtual Investor Forum Highlights Available On-Demand

Mar 13 2026Globenewswire

Life Sciences Virtual Investor Forum Agenda Announced

Mar 10 2026Globenewswire

SeaStar Medical CEO to Participate in Investor Forum

Mar 09 2026Globenewswire

SeaStar Medical CEO to Join Investor Forum

Mar 09 2026Newsfilter

SeaStar Completes Patient Enrollment in SAVE Registry for QUELIMMUNE Therapy

Mar 05 2026Newsfilter

SEASTAR MEDICAL CONFIRMS FULFILLMENT OF FDA ENROLLMENT CRITERIA FOR SAVE SURVEILLANCE REGISTRY ASSESSING QUELIMMUNE SAFETY IN PEDIATRIC AKI

Mar 05 2026moomoo

SeaStar Medical Releases Survival Data for QUELIMMUNE Therapy

Feb 09 2026Newsfilter

SeaStar Medical Expands QUELIMMUNE Adoption, Anticipates $2 Million Revenue in 2026

Jan 07 2026Globenewswire

SeaStar Medical Announces 1-for-10 Reverse Split, Shares Drop 9.5%

Dec 24 2025Benzinga

Multi Ways Holdings Reports 87.65% Revenue Growth to $26.44 Million in H1 2025

Dec 24 2025Benzinga

SeaStar Medical Executes 1-for-10 Reverse Stock Split to Meet Nasdaq Compliance

Dec 23 2025Globenewswire

What’s Happening with SeaStar Medical's Stock Today?

Dec 19 2025Benzinga